Clinical Trials on Hodgkin-betegség
Total 5256 results
-
Tessa TherapeuticsBristol-Myers SquibbActive, not recruitingClassical Hodgkin Lymphoma | Hodgkin Disease Recurrent | Hodgkin Disease RefractoryUnited States
-
West Virginia UniversityCompletedHodgkin's Lymphoma | Non-Hodgkin's LymphomaUnited States
-
Columbia UniversityMerck Sharp & Dohme LLCCompletedNon-Hodgkin's Lymphoma | Hodgkin's DiseaseUnited States
-
Cortice Biosciences, Inc.CompletedNeoplasms | Non-Hodgkin's Lymphoma | Hodgkin's DiseaseUnited States
-
Grupo Argentino de Tratamiento de la Leucemia AgudaTakedaRecruitingRefractory Hodgkin Lymphoma | Hodgkin Lymphoma, Adult | Relapsed Hodgkin's Disease, AdultArgentina
-
Memorial Sloan Kettering Cancer CenterRecruitingNon-Hodgkin Lymphoma | Non-Hodgkin's Lymphoma, Relapsed | Non-Hodgkin's Lymphoma RefractoryUnited States
-
AmgenCompletedCancer | Hodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Thrombocytopenia | Oncology | Chemotherapy-Induced Thrombocytopenia
-
PfizerCompletedHodgkin Disease | Thrombocytopenia | Non-Hodgkin LymphomaUnited States, Russian Federation, Singapore, Australia, France, Hong Kong, Greece, Poland
-
University of CologneCompleted
-
University of CologneCompleted
-
AmgenCompletedLymphoma | Hodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Oncology | Hematology
-
Genentech, Inc.CompletedChronic Lymphocytic Leukemia | Non-Hodgkins LymphomaUnited States, France, Canada, Netherlands
-
PfizerTerminatedHodgkins LymphomaUnited Kingdom, United States, Italy
-
Baylor College of MedicineNational Cancer Institute (NCI); National Institutes of Health (NIH); The Methodist... and other collaboratorsRecruitingLymphoma | Non-Hodgkin's Lymphoma | Hodgkin's Disease | Lymphoproliferative DiseaseUnited States
-
UMC UtrechtZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedNon-Hodgkin's Lymphoma | Hodgkin's Disease | Malignant LymphomaNetherlands
-
Duke UniversityGenzyme, a Sanofi CompanyCompletedMultiple Myeloma | Non-Hodgkins Lymphoma | Hodgkins DiseaseUnited States
-
AkesoPeking University Cancer Hospital & InstituteRecruiting
-
Stanford UniversityCompletedLymphoma | Hodgkin Disease | Lymphoma, Hodgkin Disease | Lymphoma: HodgkinUnited States
-
AbbottCompletedLymphoma, Non-Hodgkin | Hodgkin's LymphomaUnited States
-
Chongqing Precision Biotech Co., LtdRecruitingNon Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Relapsed Non-Hodgkin LymphomaChina
-
Columbia UniversityTerminatedHodgkin Disease | Lymphoma, Non-hodgkinUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)Completed
-
Northwestern UniversityNational Cancer Institute (NCI)Completed
-
Hoffmann-La RocheActive, not recruitingNon-Hodgkins LymphomaBelgium, Spain, Denmark, Italy, United Kingdom, Israel, United States
-
Hospital Regional de Alta Especialidad del BajioUniversidad de GuanajuatoRecruitingHodgkin Lymphoma | Refractory Hodgkin Lymphoma | Relapsed Hodgkin's Disease, AdultMexico
-
University of ChicagoRecruitingLymphoma | Hodgkin Lymphoma | Non-hodgkin LymphomaUnited States
-
Dana-Farber Cancer InstituteBristol-Myers SquibbActive, not recruitingHodgkin Lymphoma | Refractory Hodgkin Lymphoma | Relapsed Hodgkin's Disease, AdultUnited States
-
Sichuan UniversityUnknownHodgkin Lymphoma | Non-hodgkin Lymphoma
-
Divaya BhutaniGenzyme, a Sanofi CompanyRecruitingIsatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and LymphomaLymphoma | Multiple Myeloma | Non-Hodgkin Lymphoma | Relapsed Hodgkin's Disease, AdultUnited States
-
Guangzhou Gloria Biosciences Co., Ltd.Not yet recruitingRecurrent Classic Hodgkin Lymphoma | Refractory Classic Hodgkin Lymphoma | Classic Hodgkin's Lymphoma
-
Roswell Park Cancer InstituteNovartisTerminatedHodgkin's Lymphoma | Non-Hodgkin's LymphomaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLymphomaUnited States, Canada
-
Institut fuer anwendungsorientierte Forschung und...CompletedPrimary Non-Hodgkin-Lymphoma | Refractory Non-Hodgkin-Lymphoma | CD20+ Aggressive Non-Hodgkin's LymphomaGermany
-
Masonic Cancer Center, University of MinnesotaNational Cancer Institute (NCI)Withdrawn
-
University of PennsylvaniaCompletedNon-Hodgkins Lymphoma (NHL) Patients, With CD19+B Cell LymphomasUnited States
-
Montefiore Medical CenterNational Cancer Institute (NCI)Completed
-
Columbia UniversityCelgeneTerminatedLymphoma | Hodgkin Lymphoma | Lymphoid Malignancies | Non-hodgkin LymphomaUnited States
-
Children's Hospital Los AngelesCompletedHodgkins Lymphoma | Non-hodgkins LymphomaUnited States
-
University of CologneCompletedLymphocyte Predominant Hodgkin´s Lymphoma (LPHD)Germany
-
Caribou Biosciences, Inc.RecruitingLymphoma | Lymphoma, Non-Hodgkin | B Cell Lymphoma | Non Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Relapsed Non Hodgkin Lymphoma | B Cell Non-Hodgkin's LymphomaUnited States, Australia, Israel
-
National Cancer Institute (NCI)Completed
-
SIRPant Immunotherapeutics, Inc.RecruitingRefractory Non-Hodgkin Lymphoma | Relapsed Non-Hodgkin LymphomaUnited States
-
La Raza Medical CenterCompletedRefractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin LymphomaMexico
-
University of CologneCompletedNodular Lymphocyte-Predominant Hodgkin's LymphomaGermany
-
Brian HillRecruitingRefractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin LymphomaUnited States
-
The First Affiliated Hospital of Soochow UniversityShanghai Unicar-Therapy Bio-medicine Technology Co.,LtdUnknownRefractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin LymphomaChina
-
St. Jude Children's Research HospitalParexel; Jazz PharmaceuticalsCompletedAcute Lymphoblastic Leukemia | Non Hodgkins LymphomaUnited States
-
Tarapeutics Science Inc.RecruitingAdvanced Solid Tumor | Non-Hodgkin's Lymphoma, Relapsed | Non-Hodgkin's Lymphoma RefractoryChina
-
NCIC Clinical Trials GroupEli Lilly and CompanyCompleted
-
The First Affiliated Hospital of Soochow UniversityShanghai Unicar-Therapy Bio-medicine Technology Co.,LtdRecruitingRefractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin LymphomaChina